EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID ‐19: A GRADE ‐assessed systematic review and meta‐analysis of randomized controlled trials

Zohreh-Al-Sadat Ghoreshi iD, Javad Charostad iD, Nasir Arefinia iD, Mohsen Nakhaie iD, Mohammad Rezaei Zadeh Rukerd iD, Faranak Salajegheh iD

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.70013 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Zohreh-Al-Sadat Ghoreshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Drug Treatment, Dietary Supplements, Vitamin D. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic has emerged as a major global health crisis. Vitamin D, a crucial fat‐soluble vitamin, has been recommended for COVID‐19 patients, though evidence of its effectiveness is inconsistent. This systematic literature review and meta‐analysis aimed to evaluate the impact of vitamin D supplementation on COVID‐19‐related outcomes. A comprehensive search was conducted across PubMed, Scopus, Web of Science, Embase, and Cochrane databases. Primary outcomes included mortality and hospital length of stay, while secondary outcomes encompassed C‐reactive protein (CRP), ferritin, D‐dimer, hemoglobin (Hb) concentrations, and lymphocyte, neutrophil, and platelet counts. Data analysis was performed using Stata™ Version 14. A total of 16 trials were analyzed. The meta‐analysis revealed that vitamin D supplementation significantly reduced hospital length of stay (mean difference = −1.16; 95% confidence interval [CI]: −2.23, −0.09; p = .033) with significant heterogeneity ( I 2 = 69.2%, p = .002). Subgroup analysis showed a more pronounced reduction in studies with vitamin D dosages ≤10 000 international units (IU) (mean difference = −1.27; 95% CI: −1.96, −0.57; p < .001) and in patients over 60 years old (mean difference = −1.84; 95% CI: −2.53, −1.14; p < .001). Additionally, vitamin D significantly reduced CRP concentrations in older adults (>60 years) (mean difference = −1.13; 95% CI: −2.07, −0.18; p = .019). No significant changes were found in ferritin, D‐dimer, Hb concentrations, or in lymphocyte, neutrophil, and platelet counts ( p > .05). In conclusion, while vitamin D supplementation did not significantly affect most COVID‐19‐related biomarkers, however, it reduces the length of hospital stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 Drug TreatmentDietary SupplementsVitamin DAdultHumansC-Reactive ProteinFerritinsFibrin Fibrinogen Degradation ProductsLength of StayRandomized Controlled Trials as TopicSARS-CoV-2Treatment OutcomeVitamins

Stichwörter der Autor:innen

COVID‐19meta‐analysissystematic reviewvitamin D

Substanzen

C-Reactive ProteinFerritinsFibrin Fibrinogen Degradation Productsfibrin fragment DVitamin DVitamins

Autor:innen und Institutionen

  • Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
  • Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran.
  • Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
  • Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Clinical Research Development Unit, School of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.

ORCID-Profile: Zohreh-Al-Sadat Ghoreshi, Javad Charostad, Nasir Arefinia, Mohsen Nakhaie, Mohammad Rezaei Zadeh Rukerd, Faranak Salajegheh

Zitieren

APA

Ghoreshi, Z. A., Charostad, J., Arefinia, N., Nakhaie, M., Rezaei Zadeh Rukerd, M., & Salajegheh, F. (2024). Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID ‐19: A GRADE ‐assessed systematic review and meta‐analysis of randomized controlled trials. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70013

Vancouver

Ghoreshi ZA, Charostad J, Arefinia N, Nakhaie M, Rezaei Zadeh Rukerd M, Salajegheh F. Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID ‐19: A GRADE ‐assessed systematic review and meta‐analysis of randomized controlled trials. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.70013

BibTeX
@article{Ghoreshi2024,
  author = {Ghoreshi, Zohreh-Al-Sadat and Charostad, Javad and Arefinia, Nasir and Nakhaie, Mohsen and Rezaei Zadeh Rukerd, Mohammad and Salajegheh, Faranak},
  title = {Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID ‐19: A GRADE ‐assessed systematic review and meta‐analysis of randomized controlled trials},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.70013}
}
Kostenlos starten →